The Diagnostic Imaging MRI modality focus page provides information, videos, podcasts, and the latest news about industry product developments, trial results, screening guidelines, and protocol guidance that touch on the use of MRI across the healthcare continuum, including breast, neurological, cardiovascular, prostate imaging, and more.
November 21st 2024
Utilized in conjunction with hyperpolarized Xenon-129 for the assessment of lung ventilation, the chest coil can now be employed in the Signa Premier and Discovery MR750 3T MRI systems.
19th Annual New York Lung Cancers Symposium®
November 16, 2024
Register Now!
Medical Crossfire®: How Does Recent Evidence on PARP Inhibitors and Combinations Inform Treatment Planning for Prostate Cancer Now and In the Future?
View More
Medical Crossfire®: How Do the Experts Select and Sequence Therapies to Optimize Patient Outcomes and Quality of Life in Advanced Prostate Cancer?
View More
Lung Cancer Tumor Board®: Enhancing Multidisciplinary Communication to Optimize Immunotherapy in Stage I-III NSCLC
View More
Clinical Vignettes™: The Experts Explain How They Integrate PET Imaging into Metastatic HR+ Breast Cancer Care Settings
View More
School of Breast Oncology® Live Video Webcast: Clinical Updates from San Antonio
View More
Annual Hawaii Cancer Conference
January 25-26, 2025
Register Now!
21st Annual International Symposium on Melanoma and Other Cutaneous Malignancies®
February 8, 2025
View More
Community Practice Connections™: The 2nd Annual Hawaii Lung Cancers Conference®
View More
18th Annual New York GU Cancers Congress™
March 28-29, 2025
Register Now!
Clinical Case Vignette Series™: 41st Annual Miami Breast Cancer Conference®
View More
Medical Crossfire®: How Can Thoracic Teams Facilitate Optimized Care of Patients With Stage I-III EGFR Mutation-Positive NSCLC?
View More
Lung Cancer Tumor Board®: How Do Emerging Data for ICIs, BiTEs, ADCs, and Targeted Strategies Address Unmet Needs in the Therapeutic Continuum for SCLC?
View More
26th Annual International Lung Cancer Congress®
July 25-26, 2025
Register Now!
2025 International Symposium of Gastrointestinal Oncology (ISGIO)
September 12-13, 2025
Register Now!
Lung Cancer Tumor Board: Enhancing Precision Medicine in NSCLC Through Advancements in Molecular Testing and Optimal Therapy Selection
View More
(CME Credit Only) New Frontiers in Immunotherapy for SCLC: Insights From Latest Clinical Trials and Their Application in Real-World Treatment
View More
(MOC and CME Credit) New Frontiers in Immunotherapy for SCLC: Insights From Latest Clinical Trials and Their Application in Real-World Treatment
View More
(CME Credit Only) Lung Cancer Tumor Board®: The Pivotal Role of Multimodal Therapy in Leveraging Immunotherapy for Stage I-III NSCLC When the Goal Is Cure
View More
(MOC and CME Credit) Lung Cancer Tumor Board®: The Pivotal Role of Multimodal Therapy in Leveraging Immunotherapy for Stage I-III NSCLC When the Goal Is Cure
View More
Task force recommendation on prostate cancer screening galvanizes imagers
September 15th 2008Prostate cancer imaging proponents are advising physicians to follow recent federal recommendations against prostate cancer screening for men over the age of 75, but they say more government attention to care standards could lead to improved diagnosis and treatment.
Rising workload puts squeeze on academic departments
September 12th 2008A survey of academic radiologists’ clinical productivity shows that workload continues to increase, in both exam volume and complexity. Academic department heads could use the survey data to help set staffing levels and evaluate the performance of individual radiologists.
Preoperative breast imaging guides surgical management
September 5th 2008Breast cancer is the most common malignancy in adult women. One woman in 11 will contract the disease during her lifetime. The primary goal of treatment is cure, through surgery either alone or in combination with radiotherapy and/or chemotherapy. Surgical management options include breast conservation, mastectomy, and palliative treatment.
Imaging helps in diagnosis of musculoskeletal masses
September 5th 2008Primary malignant musculoskeletal tumors are an inhomogeneous group of lesions originating from mesenchymal tissues. Soft-tissue sarcomas can derive from fatty tissue (liposarcoma), muscles (leiomyosarcoma, rhabdomyosarcoma), connective tissue (fibrosarcoma), blood vessels (angiosarcoma), and neurogenic tissue (malignant peripheral nerve sheath tumor, malignant schwannoma).
Brain imaging links chronic insomnia to reversible cognitive deficits
September 4th 2008MR neuroimaging research has found that cognitive processes relating to verbal fluency are compromised in people with insomnia despite the absence of a behavioral deficit. These specific brain function alterations can be reversed, however, through nonpharmacological treatment with six weeks of sleep therapy.
MultiHance outperforms Omniscan for enhancement of brain tumors
August 29th 2008Although both gadobenate dimeglumine and gadodiamide are gadolinium-based agents, the former provides more conspicuous enhancement for imaging of brain lesions, according to results from an international multicenter trial. Findings could lead to further improvements in the management of these patients.
Head to Seoul in late October for a congress to remember
August 26th 2008The attention of the medical imaging community looks set to turn to Seoul later in October, when the 12th Asian Oceanian Congress of Radiology will be held. This is the first time the congress has been staged in Korea since its debut event in 1971, and, given the high quality of radiological practice within the country and its strong educational links with the U.S., the conference is bound to attract plenty of interest. The number and expertise of the invited speakers from North America are certainly impressive.
MRI strategy supplies early warning of osteoarthritis
August 25th 2008A novel MRI technique that tracks naturally occurring polymers in cartilage can lead to the diagnosis of early-stage osteoarthritis and may lead to better drug treatment and a reduction in the need for joint replacement surgeries.
New graphical user interface addresses MR reconstruction
August 22nd 2008Susceptibility-weighted MR imaging provides high-resolution, distortion-free blood oxygen level-dependent data for assessment of cerebral veins, blood products, and brain lesions. Currently, however, reconstruction of susceptibility-weighted imaging data is not implemented on all MR systems.
Perfusion CT approaches first-pass fMRI
August 19th 2008With piles of accumulated evidence demonstrating the ability of multislice CT to diagnose coronary artery disease, researchers are expanding clinical application of the modality to the measurement of myocardial viability following infarction.
MRI spots early biological markers of Alzheimer’s
August 14th 2008The era of postautopsy confirmation of Alzheimer’s disease may be coming to an end. MR imaging could spot signs of brain deterioration predictive of cognitive decline months, even years, before the onset of dementia, according to recent studies performed in Canada, Europe, and the U.S.
MSCT matches cardiac MRI for emergency myocardial infarction assessment
August 6th 2008Multislice CT is just as accurate as MRI in assessing myocardial infarct size in an emergency setting, according to a recent study conducted by researchers in France and the U.S. The latest data validate previous findings suggesting delayed-enhancement myocardial CT correlates well with measures of infarction size done with cardiac MR.
Diffusion-weighted MRI moves beyond brain to other body parts
August 1st 2008MR imaging can be used for many applications in oncology. Its main roles in cancer imaging are determining locoregional tumor extent, characterizing tumors, and monitoring treatment. MRI, like CT, relies on morphological criteria for lesion differentiation. This reliance, however, can make it difficult to detect small cancerous deposits and to differentiate tumor recurrence from treatment-induced tissue changes.
New medical imaging modality arises from hard work, inspiration
August 1st 2008This month's cover story ("MR elastography inspires new wave of hepatic imaging," page 20) is devoted to a rare event: the birth of a new imaging modality. MR elastography is a wonder of human ingenuity that employs MRI, a modality that itself still seems like a miracle.
Exhibitors highlight revved-up MR performance, new applications
August 1st 2008The International Society for Magnetic Resonance in Medicine is geared toward the eggheads of MR: the knob twisters who squeeze as much from their clinical scanners as they can, the experimentalists who push the limits of ultrahigh-field imaging.
Slow implementation bogs down Medicare-mandated imaging accreditation
August 1st 2008Pro-radiology forces are claiming mandated Medicare accreditation as a victory. They will have to wait until January 2012, however, to see the actual implementation of federal law passed in July to mandate accreditation for high-tech medical imaging covered by outpatient Medicare.
Whole-body PET/CT and 3T MR perform equally well for lung cancer staging
July 31st 2008No clear winner has emerged in a head-to-head comparison of whole-body FDG-PET/CT and whole-body 3T MRI for non-small cell lung cancer staging. Unenhanced PET/CT proved better for detecting metastatic lymph nodes and soft-tissue involvement, while MR was more sensitive to the presence of brain and liver metastases.
MRI zeroes in on medial meniscal tears
July 29th 2008Studies from Korea and the U.S. show that MR imaging of the knee is a reliable and accurate test for the detection of specific subtypes of medial meniscal tears. Good understanding of MR-depicted anatomic features helps identify false-positive injuries of the menisci and avoid unnecessary surgeries.
ACR wins contract to accredit government radiation oncology facilities
July 28th 2008The U.S. Department of Veterans Affairs has awarded a three-year contract to the American College of Radiology to serve as the accrediting organization for 33 VA hospital radiation oncology facilities across the country.
MRI breast cancer staging proves benefits, shortcomings
July 23rd 2008A metastudy by Australian and European researchers indicates that MR staging identifies additional disease in nearly one of five women previously diagnosed with breast cancer. It also suggests that women may undergo more extensive surgeries than originally planned because of false-positive MR findings.
Mid-year clinical update tracks radiology's course since the RSNA
July 1st 2008The RSNA is without doubt the big Kahuna of radiology medical meetings. With 60,000+ attendees and a program book that spans nearly 1000 pages in small type, the fall RSNA meeting sets the agenda for much of what goes on in radiology.
Molecular imaging enjoys progress on multiple fronts
July 1st 2008From a pivotal study that may broaden Medicare's acceptance of FDG-PET to Raman spectroscopic techniques that promise a 1000-fold improvement in sensitivity compared with fluorescence imaging, the first half of 2008 will be remembered for fruitful molecular imaging research.
CAD gains ground in climb to routine clinical application
July 1st 2008Now that computer-aided detection has become part of routine clinical work for cancer screening in mammograms and is being applied in the differential diagnosis of cancer in the lung and colon, it's only a matter of time before it rates as the standard of care for diagnostic examinations in daily clinical work.